<DOC>
	<DOC>NCT02227836</DOC>
	<brief_summary>Can allergy patch test (APT) predict of dietary therapy in patients with Eosinophilic Esophagitis?</brief_summary>
	<brief_title>Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis</brief_title>
	<detailed_description />
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<criteria>Inclusion criteria: Adults ages 1890 Patients with EoE, defined as dysphagia with histologic finding of greater than or equal to 15 eosinophils per high powered field (eos per HPF) on index esophageal biopsy Persistent symptoms and/or greater than or equal to 10 eos per HPF on esophageal biopsy after at least 8 weeks of twice daily PPI therapy Exclusion criteria: Patients with conditions known to be associated with esophageal eosinophilia, including Crohn's disease, ChurgStrauss, achalasia, and hypereosinophilic syndrome Topical swallowed steroids within 8 weeks of study enrollment Dermatologic conditions precluding application of Finn chambers to the skin for APT Inability to read due to: Blindness, cognitive dysfunction, or English language illiteracy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Allergy Patch testing</keyword>
	<keyword>Eosinophilic Esophagitis</keyword>
	<keyword>EoE</keyword>
</DOC>